Caribou Biosciences Inc

Research Caribou Biosciences Inc (CRBU) on Bullrun: market cap USD 175.55M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCRBU
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 175.55M
• Financial periodFY2025
• RevenueUSD 11.16M
• Revenue growth11.7%
• Net income-USD 148.13M
• Free cash flow-USD 112.35M

Valuation Snapshot

latest market cap is USD 175.55M.

About Caribou Biosciences Inc

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma;

Frequently asked questions

What is Caribou Biosciences Inc's market cap?

Caribou Biosciences Inc's market capitalization is USD 175.55M.

What does Caribou Biosciences Inc do?

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company.